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ABSTRACT 
 
Aims: This study investigates the hypoglycemic potential of Archachatina marginata haemolymph 
and its mechanism in streptozotocin -induced diabetic rats. 
Study Design: One factor experimental design. 
Place and Duration of Study: Department of Chemical Sciences, Joseph Ayo Babalola University, 
Ikeji Arakeji, Osun State, Nigeria between January to June, 2015. 
Methodology: The rats were set into four groups (n=5). Group 1 - Non-diabetic control (NDC), 
Group 2 - Diabetic Control (DC), Group 3 - Diabetic rats with 1 mL administration of snail 
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haemolymph (DSS1), Group 4 - Diabetic rats with 2 mL snail haemolymph administration (DSS2). 
The blood glucose concentration of each rat was taken and thereafter, they were weighed and then 
administered with 55 mg/kg STZ in citrate buffer (pH 4.5) peritoneally non-diabetic control group 
(NDC). Rats with blood glucose level of 200 mg/dL and above were considered diabetic. 
Haemolymph of 1 mL and 2 mL were administered to rats in DSS1 and DSS2 respectively while   
DC received 2 mL distilled water for 14 consecutive days. Physiological orangs and blood samples 
were harvested for various analysis. 
Results: The A. marginata haemolymph significantly improved the plasma concentration of insulin 
and reduced plasma glucose level in a dose dependent manner P=.05. 
Conclusion: The A. marginata haemolymph has potential to exact hypoglycemic effect and 
improve the insulin concentration in streptozotocin induced diabetic rat. 
 
 
Keywords: Archachatina marginata; haemolymph; streptozocin diabetes rats. 
 
1. INTRODUCTION  
 
Diabetes mellitus (DM) is a metabolic disease 
characterized by persistent hyperglycemia 
resulting from insulin deficiency or insulin 
resistance or both. It is estimated that in year 
2000 there were approximately 150 million 
individuals with the disease and that this number 
is likely to double by year 2025 [1]. Type 2 
diabetes is the fourth or fifth leading cause of 
death in most developed countries and there is 
growing evidence that it has reached epidemic 
proportions in many developing and newly 
industrialised countries [2]. High blood sugar can 
produce long-term complications such as 
cardiovascular and renal disorders, retinopathy, 
and poor blood flow [3]. Its development can be 
prevented or delayed in people with impaired 
glucose tolerance by implementing lifestyle 
changes or the use of therapeutic agents [3]. 
Despite the variety of therapies currently 
available, achieving desirable glycemic target 
has become a burden to the patients leading to 
sourcing for complementary and alternative 
medicine [4]. Recently, orthodox sources have 
continued to be valuable therapeutic agents 
especially in treating non communicable 
diseases such as snail’s hemolymph which is 
used in folk medicine [4,5]. Haemolymph is the 
blood analogue found in all arthropods and most 
mollusks which have an open circulatory system. 
It is composed of water, inorganic salts [6,7] and 
organic compounds (mostly carbohydrates, 
proteins and lipids). In the traditional ethno 
medicine of South West Nigeria, the African 
Giant Snail is included as part of recipes for the 
treatment of various ailments and diseases. It is 
believed that various preparations containing 
snails are useful in restoring fertility, virility and to 
cure smallpox [8]. Also, it is used as relieve in 
labour pains, blood loss in pregnancy and during 
delivery.  
 
 
 
Fig. 1. Live Archachatina marginata 
 
The meat of A. marginata according to scientific 
finding contains low level of sodium, fat and 
cholesterol but high in proteins, iron and calcium 
hence it’s claimed usefulness in the treatment of 
Atherosclerosis, Anaemia, Hypertension and 
Obesity [9]. Also, it has been reported that 
protein is relatively higher than other metabolites 
in the haemolymph of A. marginata [10,11,12] 
with heamocyanin a respiratory pigment as the 
major protein [10]. In continuation to source for a 
safe therapeutic agent in treating diabetes, this 
study investigates the hypoglycemic potential of 
A. marginata haemolymph and its mechanism   
in streptozotocin -induced diabetic rats. 
 
2. MATERIALS AND METHODS  
 
Reagent kits for glucose were obtained from 
Randox laboratory, USA. Streptozotocin (STZ) 
was obtained from Sigma-Aldrich (Germany).  
Other chemicals used were of analytical grade 
and obtained from FLUKA, BDH (Germany) and 
other standard commercial suppliers.  
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2.1 Animals  
 
Healthy female albino rats were acquired from 
the animal holding unit of the Institute for 
Advanced Medical Research and Training 
(IMARAT), University College Hospital, 
University of Ibadan. Animals were maintained 
with food and water ad libitum and under a 12-h 
light/12-h dark cycle. African Giant Snails were 
bought from Ipetu-Ijesa Market and taken to the 
Department of Animal Science, Joseph Ayo 
Babalola University, Ikeji Arakeji for 
authentication. The “principle of laboratory 
animal care” (National Institute of Health-NIH 
publication No. 85- 23) guidelines and 
procedures were followed in this study (NIH 
publication revised, 1985). The ethical committee 
of the department of chemical sciences, Joseph 
Ayo Babalola University, Ikeji Arakeji approved 
the research work. 
 
2.1.1 Induction of diabetes through the 
administration of streptozotocin to 
experimental animal 
 
The rats were set into four groups (n=5) for 
Streptozotocin administration.  
 
Group 1: Non-diabetic control (NDC) 
Group 2: Diabetic Control i.e. induced rats 
without haemolymph administration 
(DC)  
 Group 3: Diabetic rats with 1 mL snail 
haemolymph administered (DSS1)  
 Group 4: Diabetic rats with 2 mL snail 
haemolymph administered (DSS2)  
 
After the initial two weeks period of 
acclimatization, the animals were fasted 
overnight but allowed access to water ad libitum.  
The blood glucose concentration of each rat was 
taken and thereafter, they were weighed and 
then administered with 55 mg/kg STZ in citrate 
buffer (pH 4.5) peritoneally [13] with the 
exception of the non-diabetic control group 
(NDC) that received only citrate buffer. 
 
The rats were returned to their respective cages 
and fed glucose laden water to guide against             
the immediate hypoglycaemic effect of STZ 
administration. After three days the blood 
glucose level of the rats were again checked to 
ascertain successful diabetes inducement with 
the presence of hyperglycaemia. Rats with blood 
glucose level of 200 mg/dl and above were 
considered diabetic and used as diabetic animals 
in subsequent studies. 
2.2 Preparation of A. Marginata Snail 
Extract 
 
The whole snails were washed with copious 
amount of tap water and then rinsed with distilled 
water. The apex of the snails were opened by 
method adopted from Akinloye and Olorode [14] 
and the haemolymph collected into a clean 
beaker. It was stored at 4°C. 
 
2.3 Treatment with A. Marginata Snail 
Haemolymph 
 
The Snail haemolymph was administrated orally 
using the gastro-enteral cannula. 1 mL of 
haemolymph was administered to rats in DSS1 
while 2 mL was administered to those in DSS2. 
The diabetic control, DC, received 2 mL distilled 
water. Administration was done once a day in the 
morning for fourteen (14) consecutive days. 
 
2.4 Blood Sample Collection 
 
At the end of the fourteenth day of administration 
the animals were fasted overnight i.e. no food but 
they were given access to water. The animals 
were weighed and sacrificed by cervical 
dislocation before slicing their carotid artery with 
blade and the flowing blood was collected into 
appropriately labeled floride oxalate bottle for 
blood glucose and plain bottle for other analysis. 
The blood in the plain bottle was allowed to stand 
until effective clotting and clot retraction was 
observed. After appreciable retraction, the blood 
samples were spun at 3,000 rpm for 15 minutes 
using the centrifuge. The top supernatant i.e. the 
serum was carefully transferred to appropriately 
labeled plain tubes with the aid of a Pasteur 
pipette. Samples were immediately stored at 4°C 
till analysis. 
 
2.4.1 Organ- body weight ratio 
 
Immediately after sacrifice, vital organs such as 
liver, heart, spleen, lung and kidneys were 
quickly excised into normal saline to remove 
blood, blotted with clean laboratory tissue, freed 
of fat and then weighed. The organ to body 
weight ratio was determined by dividing the 
weight of each organ with the final body weight of 
each rat. 
 
2.4.2 Determination of blood glucose 
 
The glucose was determined after enzymatic 
oxidation in the presence of glucose oxidase. 
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The formed hydrogen peroxide reacts, under 
catalysis of peroxidase, with phenol and 4-
aminophenazone to form red-violet quinoneimine 
dye as indicator [15]. 
 
2.4.3 Determination of insulin 
 
The serum insulin quantitative determination is 
based on a solid phase enzyme – linked 
immunosorbent assay as described by Burtis and 
Edward [16]. 
 
2.4.4 Estimation of serum α-amylase activity 
 
Amylase activity assayed using enzymatic 
method of Klein et al. [16] where amylase 
hydrolyses starch at pH 6.9 to form a product 
which couple with iodine to give a coloured 
complex whose intensity is directly proportional 
to the concentration of amylase in the plasma 
when read at 590 nm. 
 
2.5 Statistical Analysis 
 
All data were subjected to one way analysis of 
variance. The mean, standard error of mean 
(SEM) and percentage were used for statistical 
analysis. The statistical significance between the 
control and each treated groups were determine 
using student t-test. The level of significance was 
set at P=.05. 
 
3. RESULTS AND DISCUSSION 
 
3.1 Effects of Snail Haemolymph on Body 
Weight of STZ Induced Diabetic Rats 
 
There was a significant reduction (P=.05) in 
weight of all the induced groups when compared 
with the non-diabetic control group (Fig. 2). After 
treatment with snail haemolymph, no significant 
improvement observed. 
 
3.2 Effects of Snail Haemolymph on Body 
Organ Ratio of STZ –Induced Diabetic 
Rats 
 
There was no significant change in major organs 
weight of all the induced groups when compared 
with the non diabetic control group (Fig. 3). 
 
3.3 Effects of Snail Haemolymph on 
Blood Glucose Concentration in STZ-
Induced Diabetic Rats 
 
The results are presented as Means ± SEM of 
five independent determinations. The 
determinations were done at 3 days interval 
commencing from the day treatment also 
commenced (D0).There was a significantly 
increase in blood glucose level (P=.05) in all the   
induced groups DSS1 and DSS2 when 
compared with the NDC throughout the period of 
 
 
Fig. 2. Effects of snail haemolymph on body weight of STZ induced diabetic rats. Each bar is 
expressed as Mean ± SEM of level of measurements of the body weights of rats in gram in 
each treatment group, (n=5). Bar carrying different alphabetical superscripts have significant 
differences (P=.05) 
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Fig. 3. Effects of snail haemolymph on body organ ratio of STZ –                                          
induced diabetic rats Each bar is expressed as Mean ± SEM of level of measurements of the 
body organs weights of rats in gram in each  group (n=5) 
 
   
Fig. 4. Effects of snail haemolymph on blood glucose concentration in STZ-induced diabetic 
rats. The results are presented as Means ± SEM of five independent determinations 
 
15 days within the six different set of samples. 
On D6, DSS2 was found to be significantly 
reduced when compared with DC. On D9, there 
were significant reduction (P=.05) in glucose 
level when DC was compared with DSS1 and 
when DC was compared with DSS2. On D12, 
there were significant reduction (P=.05) in blood 
glucose level when DC was compared 
DSS1/DSS2 and DSS1 with DSS2. Also on D15, 
there were significant reduction (P=.05) when DC 
was compared with DSS2 but with no significant 
change when compared with DSS1 (Fig. 4). 
 
3.4 Effects of Snail Haemolymph on 
Insulin Concentration in STZ-Induced 
Diabetic Rats 
 
There was a significant reduction in blood Insulin 
concentration when NDC was compared with 
each of the other groups (P=.05). Also, There 
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was significant decrease in insulin concentration 
when DC was compared with DSS1/DSS2, 
(P=.05). There was an increase in insulin 
concentration when African giant snail 
haemolymph was increased from 1 mL to 2 mL 
(DSS1 and DSS2) (p<0.05) (Fig. 5). 
 
3.5 Effects of Snail Haemolymph on 
Serum α-Amylase of STZ-Induced 
Diabetic Rats 
 
α – Amylase activities significantly increased 
when NDC was compared with each of the other 
groups (P=.05). Comparing DC with DSS1/DSS2 
showed a significant increased activities α – 
amylase (P=.05). Also, there was a significant 
decrease in α – amylase activity when comparing 
DSS1 with DSS2 (P=.05) (Fig. 6). 
 
Rats injected with streptozotocin (STZ), provide 
model of insulin-dependent diabetes mellitus with 
hyperglycaemia, loss of significant weight and 
partial deficiency in insulin activity were all 
presented by the Wistar rats in this study after 
induction prior to treatment with snail (A.  
marginata) haemolymph. This is consistent with 
earlier reports [17,18,19]. 
 
Diabetes as a metabolic disease at the onset is 
usually associated with loss of weight due to 
unavailability of glucose for metabolism in the 
tissue and increased utilization of alternative 
source of energy. This is observed in the 
significant reduction in weight of all the induced 
groups when compared with the non-diabetic 
control group. After treatment with snail 
haemolymph there was no significant 
improvement observed. Also, there was no 
significant difference in major organs weights. 
 
Diabetes is an emergency with worldwide 
financial burden on millions sufferers [20]. Its 
complications are severe and therefore needed 
cheap and available medication. Snail 
haemolymph in this study shows potential of 
being of high value in reducing blood glucose 
level at 2 mL regimen which could be attributed 
to the nutritive values associated with 
haemolymph [21]. Streptozotocin induces 
selective necrosis of beta cells of the pancreas 
that produces insulin. This degenerative process 
led to the observed significant decrease in the 
insulin concentration and the attendant DM. Snail 
haemolymph of 2 mL regimen significantly 
improved the insulin concentration over the 1 mL 
regimen. This is also reflected in the gradual and 
consistent reduction in the blood glucose 
concentration as opposed to the consistent 
increase in the diabetic control group. 
 
Plasma α- amylase consist of two forms, of 
salivary gland and pancreatic origin respectively.  
Because the salivary iso-enzyme is the principal 
form in plasma, total enzyme activity is not 
significantly lowered when the pancreatic 
secretory cell mass is reduced by chronic 
pancreatic disease. However, in acute 
pancreatitis, total plasma amylase activity is 
usually significantly increased due to release 
from damaged cells [22]. Streptozotocin damage 
of pancreatic beta cells, released the excess 
alpha amylase observed. 
 
 
 
Fig. 5. Effects of snail haemolymph on insulin concentration in STZ-induced diabetic rats. 
Each bar is expressed as Mean ± SEM of concentration of blood insulin, (n=5). Bar carrying 
different alphabetical superscripts have significant differences (P=.05) 
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Fig. 6. Effects of snail haemolymph on serum α-amylase of STZ-induced diabetic rats. Each 
bar is expressed as Mean ± SEM of concentration of blood α- amylase, (n=5). Bars with 
different alphabets superscript are significantly different (P=.05) 
 
4. CONCLUSION 
 
A. marginata haemolymph has potential to exact 
hypoglycemic effect and improve the insulin 
concentration in streptozotocin induced diabetic 
rat. 
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